FDA Adverse Event Injury Summary report: N

HEARTMATE 3 LVAS IMPLANT KIT

MDR report key: 16218611 · Received January 20, 2023

Report

Report Number
2916596-2023-00195
Event Type
Injury
Date Received
January 20, 2023
Date of Event
May 1, 2019
Report Date
January 20, 2023
Manufacturer
THORATEC CORPORATION
Product Code
DSQ
PMA / PMN Number
P160054
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MANUFACTURER'S INVESTIGATION CONCLUSION: A SPECIFIC CAUSE FOR THE REPORTED TRANSPLANT COULD NOT BE CONCLUSIVELY DETERMINED THROUGH THIS EVALUATION. ADDITIONALLY, A DIRECT CORRELATION BETWEEN HEARTMATE (HM) 3 LEFT VENTRICULAR ASSIST SYSTEM (LVAS), SERIAL NUMBER: (B)(4), AND THE EVENT(S) THAT PROMPTED THE TRANSPLANT COULD NOT BE CONCLUSIVELY ESTABLISHED. DUE TO PATIENT PRIVACY LAWS, THE ACCOUNT DECLINED TO PROVIDE PATIENT OUTCOME INFORMATION. BASED ON A REVIEW OF THE AVAILABLE PATIENT RECORDS, THERE WERE NO DEVICE ISSUES AT THE TIME OF THE PATIENT¿S TRANSPLANT, AND THE DEVICE HAD OPERATED AS INTENDED. HEARTMATE 3 LVAS, SERIAL NUMBER: (B)(4), WAS NOT RETURNED FOR EVALUATION. THE HEARTMATE 3 LVAS INSTRUCTIONS FOR USE (IFU) IS CURRENTLY AVAILABLE. ALTHOUGH NO DEVICE RELATED ISSUES WERE REPORTED BY THE ACCOUNT, THE IFU LISTS ADVERSE EVENTS THAT MAY BE ASSOCIATED WITH THE USE OF THE HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM. THE RELEVANT SECTIONS OF THE DEVICE HISTORY RECORDS FOR MLP-010079 WERE REVIEWED AND SHOWED NO DEVIATIONS FROM MANUFACTURING OR QUALITY ASSURANCE SPECIFICATIONS. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT HEART TRANSPLANTATION ON (B)(6) 2019.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1984580 HEARTMATE 3 LVAS IMPLANT KIT VENTRICULAR (ASSIST) BYPASS DSQ THORATEC CORPORATION 106524INT 6422910

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention